Cluster Analysis of Dry Eye Disease Models Based on Immune Cell Parameters - New Insight Into Therapeutic Perspective

Front Immunol. 2020 Sep 29:11:1930. doi: 10.3389/fimmu.2020.01930. eCollection 2020.

Abstract

Dry eye disease (DED) can be represented as a display of disease in the mucosal part of the eye. It is quite distinct from the retinal side of the eye which connects with the neurons and thus represents the neuroimmunological disease. DED can occur either by the internal damage of the T cells inside the body or by microbial infections. Here we summarize the most common animal model systems used for DED relating to immune factors. We aimed to identify the most important immune cell/cytokine among the animal models of the disease. We also show the essential immune factors which are being tested for DED treatment. In our results, both the mechanism and the treatment of its animal models indicate the involvement of Th1 cells and the pro-inflammatory cytokine (IL-1β and TNF-α) related to the Th1-cells. The study is intended to increase the knowledge of the animal models in the field of the ocular surface along with the opening of a dimension of thoughts while designing a new animal model or treatment paradigm for ocular surface inflammatory disorders.

Keywords: animal models; dry eye disease; helper T cells; inflammation; therapy.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Cytokines / metabolism
  • Disease Models, Animal
  • Dry Eye Syndromes / drug therapy
  • Dry Eye Syndromes / genetics
  • Dry Eye Syndromes / immunology*
  • Dry Eye Syndromes / metabolism
  • Eye / drug effects
  • Eye / immunology*
  • Eye / metabolism
  • Humans
  • Inflammation Mediators / metabolism
  • Mice
  • Rats
  • Signal Transduction
  • Th1 Cells / drug effects
  • Th1 Cells / immunology*
  • Th1 Cells / metabolism
  • Th2 Cells / drug effects
  • Th2 Cells / immunology*
  • Th2 Cells / metabolism

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Inflammation Mediators